0.98 USD
▲-0.10+1.81%
盘后 0.90 -6.50%
2026-08-03
市值
$182.68K
市盈率
—
EPS
-1218.24
股息率
—
52 周区间
0.86 – 1,297.50
成交量
100.50K
Beta
0.49
目标价
—
52W 低 0.8652W 高 1,297.50
价格走势
公司简介
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.